Kaufman HL, Kohlhapp FJ, Zloza A
CT-388 belongs to the class of incretin-based medicines that aim to regulate blood sugar and reduce appetite
(Clin Transl Med, 2021) in 24 older adults (aged 61-80) found that supplementation with GlyNAC (glycine 100 mg/kg/day + NAC 100 mg/kg/day, approximately 7 g each for a 70 kg person) for 16 weeks corrected glutathione deficiency and improved multiple hallmarks of aging including oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, body composition, exercise capacity, and cognition [10]
Regulatory status described here is current as of July 24, 2026 and is actively changing
Simply maintain your established levothyroxine routine and schedule the weekly semaglutide injection whenever fits your schedule